Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity.Obje...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Colombia Médica
Auteurs principaux: Adriana Linares Ballesteros, Roy Sanguino Lobo, Juan Camilo Villada Valencia, Oscar Arévalo Leal, Diana Constanza Plazas Hernández, Nelson Aponte Barrios, Iván Perdomo Ramírez
Format: Artigo
Langue:Inglês
Publié: Universidad del Valle 2021
Sujets:
Medicina
Child
leukemia
drug therapy
anthracyclines
echocardiography
Accès en ligne:https://www.redalyc.org/articulo.oa?id=28366572004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires